A randomized clinical trial known as the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial evaluated in African women the relative risk of HIV acquisition associated with use of three effective contraceptive methods: DMPA injections, a copper IUD and a hormonal subdermal implant. This trial was implemented to provide high-quality data on risks and benefits of available contraceptives to inform the choice of contraceptive method by women, clinicians and policy makers. This session will provide a forum to review the primary results of the ECHO trial; assess the implications of the results for women, providers, policies and programs; and elaborate on the advocacy and communications efforts to support the dissemination of the results. Discussion will be framed around informed choice for women, integration of HIV prevention and family planning, and expanding method choice – all seen as key priorities by stakeholders engaged in the ECHO trial.

• Presentations
• Map